相关实验视频

Updated: Jul 19, 2025

Engineering Oncogenic Heterozygous Gain-of-Function Mutations in Human Hematopoietic Stem and Progenitor Cells

Engineering Oncogenic Heterozygous Gain-of-Function Mutations in Human Hematopoietic Stem and Progenitor Cells

Published on: March 10, 2023

在骨髓增殖性新生瘤中向突变卡莱蒂库林的抗体向

Frederike Kramer¹, Ann Mullally^1,2,3

¹Division of Hematology, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA.

Journal of cellular and molecular medicine

|August 8, 2023

概括

在calreticulin中发生的突变通过在癌细胞上创造新的点来驱动骨髓增殖性新生瘤 (MPN). 针对这种突变calreticulin的抗体显示为MPN患者的新疗法.

科学领域:

血液学血液学血液学
免疫学免疫学免疫学
在瘤学瘤学.

背景情况:

卡莱蒂库林突变是髓增殖性新生瘤 (MPN) 的主要驱动因素.
突变的calreticulin产生了一个新的C端,异常地结合了血栓形成素受体 (MPL).
这导致细胞表面新抗原,呈现免疫治疗的目标.

研究的目的:

总结一下最近在开发突变卡尔雷蒂库林向抗体方面的进展.
探索这种方法作为MPN的新治疗策略.

主要方法:

关于突变卡莱蒂库林和MPN疗法的最新科学文献的综述.
对细胞表面新抗原的免疫向策略的分析.

主要成果:

突变卡莱蒂库林的新型C端在MPN细胞上产生特定的新抗原.
这种新抗原可用于基于抗体的向.
针对性抗体的开发是一个有希望的治疗途径.

结论:

用抗体向突变卡莱蒂库林为MPN提供了一种新的治疗策略.
针对这种特定的新抗原的免疫干预具有治疗MPN的潜力.
进一步开发这些基于抗体的疗法是有必要的.

更多相关视频

Using CRISPR/Cas9 Gene Editing to Investigate the Oncogenic Activity of Mutant Calreticulin in Cytokine Dependent Hematopoietic Cells

Using CRISPR/Cas9 Gene Editing to Investigate the Oncogenic Activity of Mutant Calreticulin in Cytokine Dependent Hematopoietic Cells

Published on: January 5, 2018

Transduction-Transplantation Mouse Model of Myeloproliferative Neoplasm

Transduction-Transplantation Mouse Model of Myeloproliferative Neoplasm

Published on: December 22, 2016

相关概念视频

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...

Abnormal Proliferation

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...